Cargando…

Renal disease progression in autosomal dominant polycystic kidney disease

BACKGROUND: Autosomal dominant polycystic kidney disease is a lifelong progressive disorder. However, how age, blood pressure, and stage of chronic kidney disease (CKD) affect the rate of kidney function deterioration is not clearly understood. METHODS: In this long-term observational case study up...

Descripción completa

Detalles Bibliográficos
Autores principales: Higashihara, Eiji, Horie, Shigeo, Muto, Satoru, Mochizuki, Toshio, Nishio, Saori, Nutahara, Kikuo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Japan 2012
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3416980/
https://www.ncbi.nlm.nih.gov/pubmed/22526483
http://dx.doi.org/10.1007/s10157-012-0611-9
_version_ 1782240471496523776
author Higashihara, Eiji
Horie, Shigeo
Muto, Satoru
Mochizuki, Toshio
Nishio, Saori
Nutahara, Kikuo
author_facet Higashihara, Eiji
Horie, Shigeo
Muto, Satoru
Mochizuki, Toshio
Nishio, Saori
Nutahara, Kikuo
author_sort Higashihara, Eiji
collection PubMed
description BACKGROUND: Autosomal dominant polycystic kidney disease is a lifelong progressive disorder. However, how age, blood pressure, and stage of chronic kidney disease (CKD) affect the rate of kidney function deterioration is not clearly understood. METHODS: In this long-term observational case study up to 13.9 years (median observation period for slope was 3.3 years), serum creatinine was serially measured in 255 mostly adult patients. The glomerular filtration rate was estimated (eGFR) using a modified Modification of Diet in Renal Disease Study method. The total kidney volume (TKV) has been measured in 86 patients at one center since 2006. RESULTS: As age increased, eGFR declined significantly (P < 0.0001), but the annual rate of decline of eGFR did not correlate with age or initially measured eGFR. In patients with CKD stage 1, eGFR declined at a rate which was not significantly different from other advanced CKD stages. Hypertensive patients had lower eGFR and larger TKV than normotensive patients at a young adult age. The slopes of regression lines of eGFR and TKV in relation to age were not different between high and normal blood pressure groups. CONCLUSION: The declining rate of eGFR was relatively constant and did not correlate with age or eGFR after adolescence. eGFR was already low in young adult patients with hypertension. As age increased after adolescence, eGFR declined and TKV increased similarly between normal and high blood pressure groups. eGFR starts to decline in patients with normal eGFR, suggesting that the decline starts earlier than previously thought. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1007/s10157-012-0611-9) contains supplementary material, which is available to authorized users.
format Online
Article
Text
id pubmed-3416980
institution National Center for Biotechnology Information
language English
publishDate 2012
publisher Springer Japan
record_format MEDLINE/PubMed
spelling pubmed-34169802012-08-16 Renal disease progression in autosomal dominant polycystic kidney disease Higashihara, Eiji Horie, Shigeo Muto, Satoru Mochizuki, Toshio Nishio, Saori Nutahara, Kikuo Clin Exp Nephrol Original Article BACKGROUND: Autosomal dominant polycystic kidney disease is a lifelong progressive disorder. However, how age, blood pressure, and stage of chronic kidney disease (CKD) affect the rate of kidney function deterioration is not clearly understood. METHODS: In this long-term observational case study up to 13.9 years (median observation period for slope was 3.3 years), serum creatinine was serially measured in 255 mostly adult patients. The glomerular filtration rate was estimated (eGFR) using a modified Modification of Diet in Renal Disease Study method. The total kidney volume (TKV) has been measured in 86 patients at one center since 2006. RESULTS: As age increased, eGFR declined significantly (P < 0.0001), but the annual rate of decline of eGFR did not correlate with age or initially measured eGFR. In patients with CKD stage 1, eGFR declined at a rate which was not significantly different from other advanced CKD stages. Hypertensive patients had lower eGFR and larger TKV than normotensive patients at a young adult age. The slopes of regression lines of eGFR and TKV in relation to age were not different between high and normal blood pressure groups. CONCLUSION: The declining rate of eGFR was relatively constant and did not correlate with age or eGFR after adolescence. eGFR was already low in young adult patients with hypertension. As age increased after adolescence, eGFR declined and TKV increased similarly between normal and high blood pressure groups. eGFR starts to decline in patients with normal eGFR, suggesting that the decline starts earlier than previously thought. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1007/s10157-012-0611-9) contains supplementary material, which is available to authorized users. Springer Japan 2012-04-21 2012 /pmc/articles/PMC3416980/ /pubmed/22526483 http://dx.doi.org/10.1007/s10157-012-0611-9 Text en © The Author(s) 2012 https://creativecommons.org/licenses/by/4.0/ This article is distributed under the terms of the Creative Commons Attribution License which permits any use, distribution, and reproduction in any medium, provided the original author(s) and the source are credited.
spellingShingle Original Article
Higashihara, Eiji
Horie, Shigeo
Muto, Satoru
Mochizuki, Toshio
Nishio, Saori
Nutahara, Kikuo
Renal disease progression in autosomal dominant polycystic kidney disease
title Renal disease progression in autosomal dominant polycystic kidney disease
title_full Renal disease progression in autosomal dominant polycystic kidney disease
title_fullStr Renal disease progression in autosomal dominant polycystic kidney disease
title_full_unstemmed Renal disease progression in autosomal dominant polycystic kidney disease
title_short Renal disease progression in autosomal dominant polycystic kidney disease
title_sort renal disease progression in autosomal dominant polycystic kidney disease
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3416980/
https://www.ncbi.nlm.nih.gov/pubmed/22526483
http://dx.doi.org/10.1007/s10157-012-0611-9
work_keys_str_mv AT higashiharaeiji renaldiseaseprogressioninautosomaldominantpolycystickidneydisease
AT horieshigeo renaldiseaseprogressioninautosomaldominantpolycystickidneydisease
AT mutosatoru renaldiseaseprogressioninautosomaldominantpolycystickidneydisease
AT mochizukitoshio renaldiseaseprogressioninautosomaldominantpolycystickidneydisease
AT nishiosaori renaldiseaseprogressioninautosomaldominantpolycystickidneydisease
AT nutaharakikuo renaldiseaseprogressioninautosomaldominantpolycystickidneydisease